MicroRNA-125b Potentiates Macrophage Activation
Abstract
MicroRNA (miR)-125b expression is modulated in macrophages in response to stimulatory cues. In this study, we report a functional role of miR-125b in macrophages. We found that miR-125b is enriched in macrophages compared with lymphoid cells and whole immune tissues. Enforced expression of miR-125b drives macrophages to adapt an activated morphology that is accompanied by increased costimulatory factor expression and elevated responsiveness to IFN-y, whereas anti–miR-125b treatment decreases CD80 surface expression. To determine whether these alterations in cell signaling, gene expression, and morphology have functional consequences, we examined the ability of macrophages with enhanced miR-125b expression to present Ags and found that they better stimulate T cell activation than control macrophages. Further indicating increased function, these macrophages were more effective at killing EL4 tumor cells in vitro and in vivo. Moreover, miR-125b repressed IFN regulatory factor 4 (IRF4), and IRF4 knockdown in macrophages mimicked the miR-125b overexpression phenotype. In summary, our evidence suggests that miR-125b is at least partly responsible for generating the activated nature of macrophages, at least partially by reducing IRF4 levels, and potentiates the functional role of macrophages in inducing immune responses.
Additional Information
© 2011 The American Association of Immunologists, Inc. Received for publication July 11, 2011. Accepted for publication September 10, 2011. This work was supported in part by National Institutes of Health Grant 1RO1AI079243-01. A.A.C. was supported by the National Science Foundation Graduate Research Fellowship Program and the Paul and Daisy Soros Fellowship for New Americans. A.Y.S. was supported by Award 1F32 CA139883-01A1 from the National Institutes of Health. N.S. was supported by the Caltech Amgen Scholars program. R.M.O. was supported by Award K99HL102228 from the National Heart, Lung, and Blood Institute. We thank Lili Yang for providing the OVA TCR-transgenic mice and the EL4-Fluc cell line.Attached Files
Accepted Version - nihms326193.pdf
Files
Name | Size | Download all |
---|---|---|
md5:59a56a6e54daa579ab8740c391f4acae
|
2.3 MB | Preview Download |
Additional details
- PMCID
- PMC3208133
- Eprint ID
- 28306
- DOI
- 10.4049/jimmunol.1102001
- Resolver ID
- CaltechAUTHORS:20111206-080652724
- NIH
- 1RO1AI079243-01
- NSF Graduate Research Fellowship
- Paul and Daisy Soros Fellowship
- NIH
- 1F32 CA139883-01A1
- Caltech Amgen Scholars Program
- NIH
- K99HL102228
- National Heart, Lung and Blood Institute
- Created
-
2011-12-06Created from EPrint's datestamp field
- Updated
-
2021-11-09Created from EPrint's last_modified field